---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248695129.md"
description: "ZHEJIANG ZHENYUAN stated on the interactive platform that the innovative new drug for cancer pain treatment is still in the exploratory research stage and there are no plans for market launch at this time"
datetime: "2025-07-16T01:10:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248695129.md)
  - [en](https://longbridge.com/en/news/248695129.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248695129.md)
---

# 

ZHEJIANG ZHENYUAN stated on the interactive platform that the innovative new drug for cancer pain treatment is still in the exploratory research stage and there are no plans for market launch at this time

### Related Stocks

- [000705.CN](https://longbridge.com/en/quote/000705.CN.md)

## Related News & Research

- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [China's top flash-memory chipmaker YMTC begins pre-IPO coaching talks with investment bank](https://longbridge.com/en/news/286879811.md)
- [Samsung Elec set to face major strike on Thursday after talks with union collapse](https://longbridge.com/en/news/287020411.md)
- [ZTE Showcases at GSMA M360 LATAM 2026, Driving Future Business Model Restructuring -- AI & Network Two-Way Integration](https://longbridge.com/en/news/286698463.md)
- [Tarter USA Announces Acquisition of Vail Products](https://longbridge.com/en/news/286956990.md)